• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑钠肽作为高血压左心室肥厚的标志物:血管紧张素转换酶抑制剂1年降压治疗期间的变化

Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.

作者信息

Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T

机构信息

First Department of Internal Medicine, Osaka City University Medical School, Japan.

出版信息

Am J Med. 1995 Mar;98(3):257-65. doi: 10.1016/S0002-9343(99)80372-6.

DOI:10.1016/S0002-9343(99)80372-6
PMID:7872342
Abstract

PURPOSE

Secretion of brain natriuretic peptide (BNP), a cardiac hormone, is accelerated via hypertrophied ventricles in experimental hypertension. The present study examined whether regression of left ventricular (LV) hypertrophy by long-term treatment with an angiotensin-converting enzyme inhibitor (ACEI) affects plasma BNP concentration in patients with essential hypertension.

PATIENTS AND METHODS

Thirty-one hypertensive patients with LV hypertrophy were treated with ACEI (16 with enalapril; 15 with lisinopril) for 1 year. Serial changes were recorded in LV mass index, LV systolic function, and plasma concentrations of BNP and atrial natriuretic peptide (ANP).

RESULTS

ACEI therapy significantly reduced LV mass index at 6 months, and more so at 1 year. Septal and posterior wall thicknesses were also reduced. Plasma BNP and ANP were markedly elevated at study entry, but only BNP levels correlated with LV mass index. Both peptide levels declined after 6 months, and this decline was enhanced at 1 year. There was a close relation between BNP decline and LV mass index reduction overall and with enalapril and lisinopril separately. Changes in ANP and in LV mass index were not related.

CONCLUSION

Long-term ACEI therapy can reduce elevated plasma BNP. In this study, changes in BNP reflected the magnitude of regression of LVH. Plasma BNP may be a useful marker for LVH during antihypertensive therapy in patients with essential hypertension and LVH.

摘要

目的

脑钠肽(BNP)是一种心脏激素,在实验性高血压中,其分泌会通过肥厚的心室加速。本研究探讨了长期使用血管紧张素转换酶抑制剂(ACEI)治疗使左心室(LV)肥厚消退是否会影响原发性高血压患者的血浆BNP浓度。

患者与方法

31例患有LV肥厚的高血压患者接受ACEI治疗(16例使用依那普利;15例使用赖诺普利),为期1年。记录LV质量指数、LV收缩功能以及BNP和心房钠尿肽(ANP)血浆浓度的系列变化。

结果

ACEI治疗在6个月时显著降低了LV质量指数,1年时降低更明显。室间隔和后壁厚度也有所减少。在研究开始时,血浆BNP和ANP显著升高,但只有BNP水平与LV质量指数相关。6个月后两种肽水平均下降,且在1年时这种下降更为明显。总体而言,BNP下降与LV质量指数降低密切相关,分别与依那普利和赖诺普利治疗也密切相关。ANP变化与LV质量指数变化无关。

结论

长期ACEI治疗可降低升高的血浆BNP。在本研究中,BNP的变化反映了LVH消退的程度。血浆BNP可能是原发性高血压合并LVH患者降压治疗期间LVH的一个有用标志物。

相似文献

1
Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.脑钠肽作为高血压左心室肥厚的标志物:血管紧张素转换酶抑制剂1年降压治疗期间的变化
Am J Med. 1995 Mar;98(3):257-65. doi: 10.1016/S0002-9343(99)80372-6.
2
Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.老年高血压左心室肥厚患者应用血管紧张素转换酶抑制剂治疗1年期间血浆心钠素浓度的变化
Int J Clin Pharmacol Ther. 1997 Jan;35(1):38-42.
3
Natriuretic peptides as markers of preclinical cardiac disease in obesity.利钠肽作为肥胖症临床前心脏疾病的标志物。
Eur J Clin Invest. 2004 May;34(5):342-8. doi: 10.1111/j.1365-2362.2004.01348.x.
4
New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.左心室肥厚患者血浆脑钠肽水平升高机制的新见解。
Can J Cardiol. 2002 Dec;18(12):1294-300.
5
Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.胰岛素样生长因子-1与原发性高血压患者心脏重量:卡托普利、赖诺普利和喹那普利的比较效应
J Hypertens Suppl. 1994 Jul;12(4):S31-6.
6
B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.高血压患者中的B型利钠肽与左心室肥厚
Rev Port Cardiol. 2003 Mar;22(3):327-36.
7
Natriuretic peptides in patients with aortic stenosis.主动脉瓣狭窄患者中的利钠肽
Am Heart J. 2001 Oct;142(4):725-32. doi: 10.1067/mhj.2001.117131.
8
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.复杂心肌梗死后长期存活者的血浆基质金属蛋白酶-2、基质金属蛋白酶-9和N末端脑钠肽前体:与左心室结构和功能的心脏磁共振成像测量的关系
J Card Fail. 2007 Dec;13(10):843-9. doi: 10.1016/j.cardfail.2007.07.006.
9
Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.血管紧张素受体拮抗剂、血管紧张素转换酶抑制剂及其联合应用对近期开始血液透析治疗的2型糖尿病患者左心室肥厚消退作用的比较
Ther Apher Dial. 2004 Aug;8(4):320-7. doi: 10.1111/j.1526-0968.2004.00142.x.
10
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.血管紧张素转换酶抑制和二氢吡啶类钙通道阻滞在治疗动脉高血压左心室肥厚中的应用
Minerva Cardioangiol. 2002 Jun;50(3):169-74.

引用本文的文献

1
Serum-Induced Expression of Brain Natriuretic Peptide Contributes to Its Increase in Patients with HFpEF.血清诱导的脑利钠肽表达导致 HFpEF 患者脑利钠肽增加。
Int J Mol Sci. 2022 Mar 10;23(6):2991. doi: 10.3390/ijms23062991.
2
The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology.基于网络药理学和实验药理学探讨黄芪甲苷IV预防高血压性心脏病进展的作用机制
Front Pharmacol. 2021 Nov 5;12:755653. doi: 10.3389/fphar.2021.755653. eCollection 2021.
3
Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure.
通过利钠肽评估的心源性充血过于简化了心力衰竭的定义和治疗。
ESC Heart Fail. 2021 Oct;8(5):3453-3457. doi: 10.1002/ehf2.13495. Epub 2021 Jul 13.
4
Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes.肾乳头顶端提取物刺激心肌细胞产生和排泄 BNP。
PLoS One. 2018 May 7;13(5):e0197078. doi: 10.1371/journal.pone.0197078. eCollection 2018.
5
Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.利钠肽在心力衰竭中的合成、分泌、功能、代谢及应用
J Biol Eng. 2018 Jan 12;12:2. doi: 10.1186/s13036-017-0093-0. eCollection 2018.
6
Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors.内皮素-1通过激活A型内皮素受体下游的持续信号传导和转录,促进心肌细胞的肥大重塑。
Cell Signal. 2017 Aug;36:240-254. doi: 10.1016/j.cellsig.2017.04.010. Epub 2017 Apr 13.
7
Plasma levels of natriuretic peptides and year-by-year blood pressure variability: a population-based study.利钠肽的血浆水平与逐年血压变异性:一项基于人群的研究。
J Hum Hypertens. 2017 Aug;31(8):525-529. doi: 10.1038/jhh.2017.14. Epub 2017 Mar 2.
8
Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.肥厚型心肌病且左心室射血分数正常患者的左心室肥厚程度决定血浆N末端脑钠肽前体水平。
Clin Cardiol. 2006 Apr;29(4):155-60. doi: 10.1002/clc.4960290406.
9
Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.长期使用橡果心脏支持装置治疗后,心力衰竭犬左心室心肌中适应性不良基因程序的逆转。
Heart Fail Rev. 2005 Jun;10(2):157-63. doi: 10.1007/s10741-005-4643-z.
10
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.缬沙坦与依那普利对充血性心力衰竭患者心脏交感神经活性及血浆脑钠肽的比较效应
Heart. 2006 May;92(5):625-30. doi: 10.1136/hrt.2005.062463. Epub 2005 Sep 13.